CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.44
−0.83%Aug 14, 2026, 20:05 UTC
Cue Biopharma reported its financial results for the second quarter of 2026.
Source:Aug 14, 2026, 00:00 UTC
Cue Biopharma announced a private placement of securities to raise approximately $50 million in gross proceeds.
Aug 3, 2026, 12:30 UTC
Cue Biopharma announced the appointment of James M. Ahlers as Chief Financial Officer on August 3, 2026.
Source:Jul 10, 2026, 01:40 UTC
Cue Biopharma announced a private placement of common stock and pre-funded warrants to accredited investors for gross proceeds of approximately $50.0 million.
Source:Jun 2, 2026, 20:05 UTC
Cue Biopharma announced the resignation of four independent directors and the addition of two new directors to its board.
Source:Jun 2, 2026, 00:00 UTC
Cue Biopharma appointed Sumita Ray as Chief Legal & Compliance Officer and Corporate Secretary.